ZISI BERKOWITZ: Open Payments
NPI 1578295762 · OSSINING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,066 in 216 payments from 15 companies in 2025. Trend: 2023 $954 · 2024 $4,188 · 2025 $4,066
Food & beverage: $4,066
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 35 | $766 |
| Janssen Biotech, Inc. | 34 | $623 |
| Arcutis Biotherapeutics, Inc. | 17 | $418 |
| Galderma Laboratories, L.P. | 17 | $411 |
| LEO Pharma Inc. | 22 | $371 |
| Organon LLC | 22 | $264 |
| Botanix SB Inc | 11 | $249 |
| ABBVIE INC. | 17 | $192 |
| Lilly USA, LLC | 7 | $183 |
| Amgen Inc. | 8 | $176 |
Products named: OPZELURA, TREMFYA, Zoryve, NEMLUVIO, DUPIXENT, ADBRY, SOFDRA, VTAMA.
Industry payments across NY — which companies pay providers there.
